215 related articles for article (PubMed ID: 21354661)
1. [False positive of intramammary sentinel node].
Fuertes J; Mestre-Fusco A; Suárez M; Plancarte F; Munné-Collado J; Vidal-Sicart S
Rev Esp Med Nucl; 2011; 30(2):112-3. PubMed ID: 21354661
[No Abstract] [Full Text] [Related]
2. False positive of intramammary sentinel lymph node in lymphoscintigraphy.
Lanchas Alfonso I; Miguel Martínez MB; García Higuera MI; Montero Ruiz JB; Aragón Martinez J; Duque Gallo JJ
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):161-2. PubMed ID: 21944192
[No Abstract] [Full Text] [Related]
3. [Intramammary sentinel lymph node preoperative identification with SPECT/CT in a patient with breast cancer. Clinical meaning and relevance].
Andrés A; Prats E; Santapau A; Tardín L; Razola P; Parra A; Rambalde EF; Banzo J
Rev Esp Med Nucl; 2011; 30(2):101-3. PubMed ID: 21334108
[TBL] [Abstract][Full Text] [Related]
4. [Notification of an adverse effect to human albumin (⁹⁹m)Tc-nanocolloid].
Cotrina-Monroy A; Perez-Iruela JA; Lopez-López A; De Juan R; Rodríguez-Torras ML; Gómez Embuena A
Rev Esp Med Nucl; 2010; 29(6):308-9. PubMed ID: 20880609
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
6. The effect of radiocolloid preference on major parameters in sentinel lymph node biopsy practice in breast cancer.
Yararbas U; Argon AM; Yeniay L; Zengel B; Kapkaç M
Nucl Med Biol; 2010 Oct; 37(7):805-10. PubMed ID: 20870155
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral versus intraparenchymal injection technique for lymphoscintigraphy in breast cancer.
Estourgie SH; Nieweg OE; Valdés Olmos RA; Th Rutgers EJ; Kroon BB
Clin Nucl Med; 2003 May; 28(5):371-4. PubMed ID: 12702931
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
[TBL] [Abstract][Full Text] [Related]
9. The sentinel node in breast cancer--a multicenter validation study.
Krag D; Weaver D; Ashikaga T; Moffat F; Klimberg VS; Shriver C; Feldman S; Kusminsky R; Gadd M; Kuhn J; Harlow S; Beitsch P
N Engl J Med; 1998 Oct; 339(14):941-6. PubMed ID: 9753708
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
11. [Micrometastasis in the sentinel node and axillary lymph node macro-metastasis in breast cancer].
Cordero García JM; Delgado Portela M; García Vicente AM; Pilkington Woll JP; Palomar Muñoz MA; Poblete García VM; Bellón Guardia ME; Pardo García R; Rabadán Ruiz L; Soriano Castrejón AM
Rev Esp Med Nucl; 2010; 29(3):122-6. PubMed ID: 20398965
[TBL] [Abstract][Full Text] [Related]
12. Bilateral axillary sentinel nodes from breast carcinoma.
Chakera AH; Law I; Friis E; Ingvar C; Hesse B
Clin Nucl Med; 2004 Dec; 29(12):840. PubMed ID: 15545900
[No Abstract] [Full Text] [Related]
13. [Subareolar injection for sentinel lymph node biopsy in multiple breast cancer].
D'Eredità G; Troilo VL; Giardina C; Ingravallo G; Rubini G; Lattanzio V; Berardi T
G Chir; 2006; 27(11-12):436-41. PubMed ID: 17198554
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
[TBL] [Abstract][Full Text] [Related]
15. Combined radioguided nonpalpable lesion localization and sentinel lymph node biopsy for early breast carcinoma.
Barros AC; Barros MA; Andrade FE; Mori LJ; Costa PA; Sheng PY; Pelizon CH
Ann Surg Oncol; 2007 Apr; 14(4):1472-7. PubMed ID: 17225979
[TBL] [Abstract][Full Text] [Related]
16. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
[TBL] [Abstract][Full Text] [Related]
17. Sentinel node biopsy for breast cancer.
Tafra L
Minerva Chir; 2002 Aug; 57(4):425-35. PubMed ID: 12145572
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer, Poland's syndrome, and sentinel lymph node involvement.
Uña J; Vega V; Gutierrez I; Herrera J; Hernández-Briz MJ
Clin Nucl Med; 2007 Aug; 32(8):613-5. PubMed ID: 17667433
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy in the treatment of breast cancer. Experience in 527 cases.
Procaccini E; Ruggiero R; Docimo G; Iovino F; Procaccini F; De Luca R; Irlandese E; Gili S; Lo Schiavo F
Minerva Chir; 2007 Apr; 62(2):93-9. PubMed ID: 17353851
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
